person
as of 2026-07-01Mark Smith
at a glance
Roles: Study Director, Author
KOL signal score 2
1 publications · 0 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
AstraZeneca1800 Concord PikeWilmington, DE, 19850
Roles
Study Director, Author
KOL signal
2
Publications
1 (0 high-value)
Trial investigator
no
Publishes on
1 drugs
Trials led
1
Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients
NCT00921804Phase 2Completed
Publications & congress
1
Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine.
Molecular psychiatry · 2021
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
drug